Answers are grounded in this paper and cite their sources.
OSAHS patients may present with hypercoagulation and relatively high-risk of recurrence of PE after cessation of 6-month warfarin treatment.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: